Product Images Darifenacin

This is a prescription-only medication with the NDC code 69097-431-02. Each extended-release tablet contains 8.929 mg of darifenacin E hydrobromide, providing 7.5 mg of darifenacin. The medication is meant for oral consumption and should be kept out of the reach of children. The tablets need to be stored at a temperature of 25°C (77°F), with excursions between 15°C to 30°C (59°F to 86°F) permitted. The manufacturer is Cipla Ltd. and the medication is sold in a pack of 30 tablets. Expiry and batch information are overprinted during commercial packing.*

This is a description of a medication with the NDC number 69097-432-02, which is a prescription-only medication. Each tablet is a film-coated extended-release tablet containing 17.858 mg of darifenacin hydrobromide to provide 15 mg darifenacin. The recommended adult dosage is one tablet per day. The tablets should be kept out of the reach of children, stored at 25°C (77°F) with excursions allowed between 15°C to 30°C (59°F to 86°F), and protected from light. The manufacturer is Clpla Ltd. in India, and the medication is manufactured for Clpla USA, Inc. There are 30 tablets per bottle. Information on the batch number, serial number, expiry, and lot will be overprinted during commercial packing.*